MedTrace Logo

The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis

NCT01688180 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2013-08-07

No results posted yet for this study

Summary

Patients with chronic diseases are at great risk of depression and anxiety.It is known that depression and anxiety are one of the most common comorbidities associated with chronic lung diseases such as asthma and chronic obstructive pulmonary disease.

However,to date,little is known about the rates and risk factors of depression and anxiety symptoms in non-CF bronchiectasis;and no large-scale prospective studies have been performed to investigate the effect of depression and anxiety on the healthy outcomes(such as number of exacerbations and hospitalizations over the ensuing year).Our purpose is to fill these gaps.

Conditions

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Principal Investigators

  • Yongchang Chen, professor · The First Affiliated Hospital of Guangzhou Medical University

  • Nanshan Zhong, Professor · The First Affiliated Hospital of Guangzhou Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01688180 on ClinicalTrials.gov